A Study to Evaluate The Effects Of a Multivitamin/Mineral With Ginko In Subjects With Age Associated Memory Impairment
NCT01160692 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2010-08-02
Summary
A Study to evaluate the cognitive effects and tolerance of a Multi-Vitamin/Mineral Preperation containing Gingko in elderly subjects with age associated memory impairment.
Conditions
- Age-Related Memory Disorders
Interventions
- DIETARY_SUPPLEMENT
-
Multivitamin/Multimineral/Ginkgo (BAY 81-2775)
Multivitamin/Multimineral/Ginkgo (BAY 81-2775), daily oral intake of film coated tablets for 3 months
- OTHER
-
Placebo
Daily oral intake of matching placebo tablets for 3 months
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Plant Based Nootropic on Perceptual Decision Making.
NCT06689644 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
NCT01600859 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
NCT06562114 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders
NCT01637168 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
NCT00663936 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Fermented Codonopsis Lanceolata on Improvement in Cognitive-Bio-Markers of Cognitive Functions
NCT03439098 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women
NCT03835325 ·Status: COMPLETED ·Phase: NA
-
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613 ·Status: RECRUITING ·Phase: PHASE1
-
Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment
NCT05289804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age
NCT02576639 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease
NCT00414622 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Colon-delivered Multivitamin Supplement on Brain Functioning, Immunometabolic- and Intestinal Markers in Ageing
NCT05675007 ·Status: COMPLETED ·Phase: NA
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects
NCT04832412 ·Status: COMPLETED ·Phase: NA
-
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
NCT01702480 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Trial of a Nutritional Supplement in Alzheimer's Disease
NCT00678431 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
NCT02553928 ·Status: COMPLETED ·Phase: PHASE4
-
A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients
NCT01656525 ·Status: COMPLETED ·Phase: PHASE1
-
Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient
NCT05690724 ·Status: RECRUITING ·Phase: NA